Keros Therapeutics (KROS) PT Lowered to $41 at Scotiabank
Tweet Send to a Friend
(Updated - January 16, 2025 6:59 AM EST)
Scotiabank analyst Greg Harrison lowered the price target on Keros Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Scotiabank analyst Greg Harrison lowered the price target on Keros Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
